HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Carbamazepine

Carbamazepine

This drug is used to treat epilepsy and diseases that induce seizures because it contains anticonvulsant characteristics. It is the medication that is prescribed in oral dose forms available including chewable tablets, immediate-release tablets, extended-release tablets, and extended-release capsules. There is also an intravenous (IV) form available. It is also a generic medication. Oftentimes, generic drugs are less expensive than name brands. The brand-name medicine may not always be available in every dose form or strength. Schizophrenia is also treated with it in combination with several medications. It is furthermore used as a second-line drug for the treatment of the bipolar disorder. Some common side effects of carbamazepine include constipation, tiredness, drowsiness, and disorders of voluntary movement.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom

Submit your abstract Today

Whatsapp